Alberto Sobrero
About
Alberto Sobrero is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine.
According to data from OpenAlex, Alberto Sobrero has authored 207 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Oncology, 80 papers in Pulmonary and Respiratory Medicine and 41 papers in Pathology and Forensic Medicine. Recurrent topics in Alberto Sobrero's work include Colorectal Cancer Treatments and Studies (154 papers), Cancer Treatment and Pharmacology (70 papers) and Gastric Cancer Management and Outcomes (53 papers). Alberto Sobrero is often cited by papers focused on Colorectal Cancer Treatments and Studies (154 papers), Cancer Treatment and Pharmacology (70 papers) and Gastric Cancer Management and Outcomes (53 papers). Alberto Sobrero collaborates with scholars based in Italy, United States and France. Alberto Sobrero's co-authors include Eric Van Cutsem, Thierry André, Josep Tabernero, C. Aschele, Joseph R. Bertino, Marc Ychou, Daniel J. Sargent, Heinz‐Josef Lenz, Salvatore Siena and Axel Grothey and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
In The Last Decade
Alberto Sobrero
197 papers receiving 11.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Alberto Sobrero Italy | 45 | 9.6k | 3.9k | 2.7k | 2.3k | 2.0k | 207 | 12.1k | ||
| Fernando Rivera Spain | 41 | 10.2k 1.1× | 4.7k 1.2× | 2.6k 1.0× | 1.9k 0.8× | 2.6k 1.3× | 168 | 12.9k | ||
| Christos S. Karapetis Australia | 42 | 8.2k 0.8× | 3.8k 1.0× | 1.3k 0.5× | 2.8k 1.2× | 1.6k 0.8× | 314 | 11.2k | ||
| Niall C. Tebbutt Australia | 48 | 9.3k 1.0× | 4.4k 1.1× | 1.7k 0.6× | 2.6k 1.1× | 3.0k 1.5× | 255 | 12.8k | ||
| Eduardo Díaz‐Rubio Spain | 49 | 8.7k 0.9× | 3.5k 0.9× | 2.0k 0.7× | 1.9k 0.8× | 2.4k 1.2× | 351 | 12.0k | ||
| Jim Cassidy United Kingdom | 42 | 9.4k 1.0× | 3.1k 0.8× | 2.4k 0.9× | 1.5k 0.6× | 2.3k 1.2× | 122 | 11.7k | ||
| Arié Figer Israel | 35 | 11.6k 1.2× | 4.1k 1.0× | 3.4k 1.3× | 1.9k 0.8× | 2.6k 1.3× | 107 | 14.6k | ||
| Axel Grothey United States | 57 | 14.2k 1.5× | 4.9k 1.3× | 3.3k 1.2× | 3.9k 1.7× | 3.5k 1.8× | 331 | 18.6k | ||
| Gunnar Folprecht Germany | 37 | 8.6k 0.9× | 3.6k 0.9× | 3.1k 1.1× | 2.5k 1.1× | 2.2k 1.1× | 198 | 10.7k | ||
| Thomas H. Cartwright United States | 25 | 7.3k 0.8× | 3.0k 0.8× | 2.0k 0.7× | 1.1k 0.5× | 1.5k 0.8× | 81 | 11.2k | ||
| C. Boni Italy | 34 | 11.0k 1.1× | 5.5k 1.4× | 1.7k 0.6× | 2.1k 0.9× | 3.3k 1.7× | 122 | 13.9k |
Countries citing papers authored by Alberto Sobrero
Since
Specialization
Citations
This map shows the geographic impact of Alberto Sobrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Sobrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Sobrero more than expected).
Fields of papers citing papers by Alberto Sobrero
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Alberto Sobrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Sobrero. The network helps show where Alberto Sobrero may publish in the future.
Co-authorship network of co-authors of Alberto Sobrero
This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Sobrero. A scholar is included among the top collaborators of Alberto Sobrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Sobrero. Alberto Sobrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Pinto, Carmine, Sara Lonardi, Evaristo Maiello, et al.. (2025). Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion. Frontiers in Oncology. 14. 1502185–1502185.
2.
Bekaii‐Saab, Tanios, Arvind Dasari, Cathy Eng, et al.. (2024). Efficacy and safety of fruquintinib in patients with metastatic colorectal cancer according to prior treatment sequence in the refractory setting: Results from FRESCO and FRESCO-2.. Journal of Clinical Oncology. 42(16_suppl). 3579–3579.
3.
Karapetis, Christos S., Michael J. Sorich, Levi Pederson, et al.. (2024). Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database. British Journal of Cancer. 130(8). 1269–1278.
4.
Cremolini, Chiara, Clara Montagut, Philippe Ronga, et al.. (2023). Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer. Frontiers in Oncology. 12. 946850–946850.
5.
Martelli, Valentino, Liliana Belgioia, Fabio Catalano, et al.. (2023). The controversial abscopal effect: A single-center experience about the combination of stereotactic radiotherapy with pembrolizumab in patients with metastatic dMMR/MSI-H colorectal cancer.. Journal of Clinical Oncology. 41(16_suppl). 2608–2608.
6.
Pastorino, Alessandro, Marta Ponzano, Massimiliano Grassi, et al.. (2023). Reliability of patient-reported toxicities during adjuvant chemotherapy. European Journal of Cancer. 182. 115–121.
7.
Dasari, Arvind, Alberto Sobrero, James C. Yao, et al.. (2021). FRESCO-2: A Global Phase III Study Investigating the Efficacy and Safety of Fruquintinib in Metastatic Colorectal Cancer. Future Oncology. 17(24). 3151–3162.
8.
Bregni, Giacomo, Stefania Sciallero, & Alberto Sobrero. (2019). HER2 Amplification and Anti-EGFR Sensitivity in Advanced Colorectal Cancer. JAMA Oncology. 5(5). 605–605.
9.
Sobrero, Alberto, Axel Grothey, Timothy Iveson, et al.. (2018). The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?. Annals of Oncology. 29(5). 1099–1107.
10.
Cutsem, Eric Van, Kei Muro, David Cunningham, et al.. (2016). O-007 Biomarker analyses of second-line ramucirumab in patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study. Annals of Oncology. 27. ii120–ii120.
11.
Sobrero, Alberto, Luciano Latini, C. Barone, et al.. (2015). Review of RAISE, a Randomized, Double-Blind, Multicenter Phase III Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (RAM) or Placebo (PBO) in Patients (pts) With Metastatic Colorectal Carcinoma (mCRC) Progressive During or Following First-Line Combination Therapy With Bevacizumab (bev), Oxaliplatin (ox), and a Fluoropyrimidine (fp): Primary Results and Subgroup Analysis by KRAS Status. Annals of Oncology. 26. vi37–vi37.
12.
Tabernero, Josep, Rocio García‐Carbonero, James T. Cassidy, et al.. (2013). Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial. Clinical Cancer Research. 19(9). 2541–2550.
13.
Schmoll, Hans‐Joachim, David Cunningham, Alberto Sobrero, et al.. (2012). Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III). Journal of Clinical Oncology. 30(29). 3588–3595.
14.
Peeters, Marc, Timothy Price, Andrés Cervantes, et al.. (2010). Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 28(31). 4706–4713.
15.
Price, Timothy, Niall C. Tebbutt, Christos S. Karapetis, et al.. (2010). Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008. Clinical Colorectal Cancer. 9(1). 8–14.
16.
Sartore‐Bianchi, Andrea, Mauro Moroni, Silvio Veronese, et al.. (2007). Epidermal Growth Factor Receptor Gene Copy Number and Clinical Outcome of Metastatic Colorectal Cancer Treated With Panitumumab. Journal of Clinical Oncology. 25(22). 3238–3245.
17.
Sobrero, Alberto & Gaetano Berruto. (2002). La variazione e gli usi.
18.
Sobrero, Alberto, et al.. (1997). Fondamenti di dialettologia italiana. Laterza eBooks. 1–424.
19.
Sobrero, Alberto, et al.. (1992). Il Linguaggio giovanile degli anni Novanta : regole, invenzioni, gioco. Laterza eBooks.
20.
Berruto, Gaetano & Alberto Sobrero. (1990). Studi di sociolinguistica e dialettologia italiana : offerti a Corrado Grassi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Fernando Rivera Breakdown of academic impact, for papers by Christos S. Karapetis Breakdown of academic impact, for papers by Niall C. Tebbutt Breakdown of academic impact, for papers by Eduardo Díaz‐Rubio Breakdown of academic impact, for papers by Jim Cassidy Breakdown of academic impact, for papers by Arié Figer Breakdown of academic impact, for papers by Axel Grothey Breakdown of academic impact, for papers by Gunnar Folprecht Breakdown of academic impact, for papers by Thomas H. Cartwright Breakdown of academic impact, for papers by C. Boni